Exercise and Bright Light Treatment: Effects on Body Weight and Composition
Moderate Exercise and Bright Light Treatment in Overweight Individuals
1 other identifier
interventional
24
1 country
1
Brief Summary
Bright light therapy has been used to safely and effectively treat conditions such as Seasonal Affective Disorder and to regularize sleep in patients with circadian rhythm disorder. Based on evidence of the link between bright light, serotonin, mood and carbohydrate metabolism, it has been suggested that bright light therapy can improve weight loss but the literature on the subject is sparse. Further, the literature suggests that apart from any changes in mood and carbohydrate metabolism, bright light may reduce the unpleasant side-effects of exercise and increase compliance to an exercise program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2 obesity
Started Sep 2003
Shorter than P25 for phase_2 obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2003
CompletedFirst Submitted
Initial submission to the registry
October 4, 2006
CompletedFirst Posted
Study publicly available on registry
October 6, 2006
CompletedOctober 6, 2006
July 1, 2006
October 4, 2006
October 4, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome measure will be the amount of weight loss.
Secondary Outcomes (1)
Secondary outcome measures will be the ratings of mood on the POMS, CES-D and SPAQ
Interventions
Eligibility Criteria
You may qualify if:
- Overweight subjects
- Subjects in otherwise good health
- Subjects willing to participate in a 6-week moderate exercise program
- Bedtime between 10pm and 12am; wake-up time between 6am and 8am
- Score in the median range of the Morningness/ Eveningness Questionnaire (i.e., subjects show no distinct characteristics of phase delay or phase advance)
You may not qualify if:
- Progressive eye disease
- History of cataracts, macular degeneration or have undergone laser corrective eye surgery in the past 30 days.
- Currently taking any medications, e.g. antibiotics, tricyclic antidepressants, that may affect photosensitivity
- History of heart disease
- History of respiratory diseases, such as asthma, emphysema
- Any severe or uncontrolled general medical condition
- Severe psychiatric disorder (as determined by psychiatrist - CMS)
- History of mania
- Grossly obese individuals with morbid obesity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Health Network, Torontolead
- The Litebook Company Ltd.collaborator
Study Sites (1)
University Health Network
Toronto, Ontario, M5T 2S8, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Colin M. Shapiro, MBBCh, PhD
University Health Network, Toronto
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 4, 2006
First Posted
October 6, 2006
Study Start
September 1, 2003
Study Completion
December 1, 2003
Last Updated
October 6, 2006
Record last verified: 2006-07